Topical corticosteroid-induced acne. Three treatment strategies to break the 'addiction' cycle.
Brodell
R T
RT
Northeastern Ohio Universities College of Medicine, Rootstown, USA. rtb@neoucom.edu
O'Brien
M J
MJ
D000152:Acne Vulgaris / Q000139:chemically induced*; D000279:Administration, Cutaneous; D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000891:Anti-Infective Agents, Local / Q000009:adverse effects; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D001623:Betamethasone / Q000009:adverse effects; D002675:Child, Preschool; D002981:Clindamycin / Q000008:administration & dosage / Q000627:therapeutic use; D003022:Clotrimazole / Q000009:adverse effects; D003898:Desonide / Q000009:adverse effects; D004890:Erythema / Q000139:chemically induced; D015643:Erythromycin Ethylsuccinate / Q000008:administration & dosage / Q000627:therapeutic use; D005148:Facial Dermatoses / Q000139:chemically induced*; D005260:Female; D005938:Glucocorticoids; D006801:Humans
D000900:Anti-Bacterial Agents; D000891:Anti-Infective Agents, Local; D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D015643:Erythromycin Ethylsuccinate; D002981:Clindamycin; D001623:Betamethasone; D003022:Clotrimazole; D003898:Desonide